Stay updated with breaking news from Professor Rick Tarleton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Enrollment well underway in Phase 3 part of pivotal Phase 2/3 study of epetraborole in treatment-refractory Mycobacterium avium complex lung disease On track to announce Phase 2 clinical data...
License enables advancement of AN2-502998 (formerly known as AN15368), a boron-based small molecule therapeutic under development for the treatment of Chagas disease IND-enabling preclinical studies well underway in
License enables advancement of AN2-502998 , a boron-based small molecule therapeutic under development for the treatment of Chagas disease IND-enabling preclinical studies well underway in...